Lucis

France
Artannes-sur-Indre, Centre-Val de Loire, France, 37260

Company profile

Lucis company profile

Lucis provides a health technology platform focused on biological age measurement and longevity-oriented insights using advanced diagnostics and data analysis. The company offers blood-based testing and biomarker analysis designed to assess physiological aging processes rather than chronological age. Its services translate laboratory results into structured reports that highlight metabolic health, inflammation, cellular function, and other biological indicators relevant to long-term health management. Lucis also delivers a digital interface where individuals can track changes in biological markers over time and review personalized, data-driven recommendations related to lifestyle, nutrition, and health optimization. The platform is designed for both individual users and professionals who incorporate biological age data into preventive health or wellness programs. Through its combination of diagnostics, analytics, and reporting tools, Lucis supports ongoing monitoring of health trends and informed decision-making around aging and longevity.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2024-01-01, Year

Headquarters

Postal code
37260
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$8.5M
Last funding
Seed / $8.5M / 2025-12-16
Last equity funding
Seed / $8.5M
Investors
7
Lead investors
1
Founders
3
Articles
7

Founders and investors

Founders

Baptiste DebeverMax GueroisMaxime Berthelot

Lead investors

General Catalyst

Investors

General CatalystKima VenturesMotier VenturesRebel FundY Combinator